Magnetic Marker Monitoring: High resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 74, Issue 1, 2010, Pages 93-101

  Weitschies, Werner ^a   Blume, Henning ^b   Mönnikes, Hubert ^c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b SocraTec R and D GmbH   (Germany)

^c Martin Luther Hospital   (Germany)

Author keywords

Colon transit; Gastric emptying; In vivo dissolution; IVIVC; Magnetic Marker Monitoring; Oral dosage forms; Review; Small intestinal transit time

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AUGMENTIN XR; UNCLASSIFIED DRUG;

BIOMAGNETISM; DIPOLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LABELING; DRUG MONITORING; DRUG RELEASE; DRUG SOLUBILITY; FOOD; FOOD DRUG INTERACTION; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HUMAN; HYDROGEL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE TRANSIT TIME; MAGNETIC FIELD; MATRIX TABLET; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REVIEW; SMALL INTESTINE; STOMACH EMPTYING; SUSTAINED DRUG RELEASE; TABLET DISINTEGRATION;

ADMINISTRATION, ORAL; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; ELECTROMAGNETIC PHENOMENA; FEMALE; FOOD-DRUG INTERACTIONS; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; SOLUBILITY; TABLETS, ENTERIC-COATED; TECHNOLOGY, PHARMACEUTICAL;

EID: 72149105321     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.07.007     Document Type: Review

References (43)

1. Halperin J.A. Product selection, bioequivalence, and therapeutic equivalence: the generic drug market. Drug Inf. J. 17 (1983) 73-76
2. Horton R.E., Ross F.G.M., and Darling G.H. Determination of the emptying-time of the stomach by use of enteric-coated barium granules. Br. Med. J. 1 (1965) 1537-1539
3. Steinberg W.H., Frey G.H., Masci J.N., and Hutchins H.H. Method for determining in vivo tablet disintegration. Pharm. Sci. 54 (1965) 747-752
4. Hardy J.G., and Wilson C.G. Radionuclide imaging in pharmaceutical, physiological and pharmacological research. Clin. Phys. Physiol. Meas. 2 (1981) 71-121
5. Casey D.L., Beihn R.M., Digenis G.A., and Shabhu M.B. Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy. J. Pharm. Sci. 65 (1976) 1412-1413
6. Digenis G.A., Sandefer E.P., Parr A.F., Beihn R., McClain C., Scheinthal B.M., Ghebre-Sellassie I., Iyer U., Nesbitt R.U., and Randinitis E. Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy. J. Clin. Pharmacol. 30 (1990) 621-631
7. Podczeck F., Course N.J., and Newton J.M. Determination of the gastric emptying of solid dosage forms using gamma-scintigraphy: a problem of image timing and mathematical analysis. Eur. J. Nucl. Med. 26 (1999) 373-378
8. Goodman K., Hodges L.A., Stevens H.N.E., Weitschies W., and Wilson C.G. Assessing gastrointestinal motility and disintegration profiles of magnetic tablets by a novel magnetic imaging device and gamma scintigraphy. Eur. J. Pharm. Biopharm. 74 (2009) 84-92
9. Weitschies W., Wedemeyer J., Stehr R., and Trahms L. Magnetic markers as a noninvasive tool to monitor gastrointestinal transit. IEEE Trans. Biomed. Eng. 41 (1994) 192-195
10. Weitschies W., Kosch O., Mönnikes H., and Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 57 (2005) 1210-1222
11. Davis S.S., Hardy J.G., Newman S.P., and Wilding I.R. Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur. J. Nucl. Med. 19 (1992) 971-986
12. M. Anschütz, G. Garbacz, O. Kosch, F. Donath, J. Wiedmann, W Hoeckh, L Trahms, B. Schug, W. Weitschies, H. Blume, Characterization of the behaviour of alginate-based microcapsules in vitro and in vivo, Int. J. Clin. Pharmacol. Ther., in press.
13. Osmanoglou E., Van Der Voort I.R., Fach K., Kosch O., Bach D., Hartmann V., Strenzke A., Weitschies W., Wiedenmann B., Trahms L., and Mönnikes H. Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity. Neurogastroenterol. Motil. 16 (2004) 547-556
14. Drung D. The PTB 83-SQUID system for biomagnetic applications in a clinic. IEEE Trans. Appl. Supercond. 5 (1995) 2112-2117
15. Schnabel A., Burghoff M., Hartwig S., Petsche F., Steinhoff U., Drung D., and Koch H. A sensor configuration for a 304 SQUID vector magnetometer. Neurol. Clin. Neurophysiol. (2004) 70
16. J. Bork, H.D. Hahlbohm, R. Klein, A. Schnabel, The 8-layered magnetically shielded room of the PTB: Design and construction, in: J. Nenonen, R.J. Ilmoniemi, T. Katila (Eds.), Biomag 2000, Proc. 12th Int. Conf. on Biomagnetism, Helsinki Univ. of Technology, Espoo, Finland, 2001, pp. 970-973.
17. Marquardt D.W. J. Soc. Ind. Appl. Math. 11 (1963) 431-441
18. Press W.H., Teukolsky S.A., Vetterling W.T., and Flannery B.P. Numerical Recipes in C (1995), Cambridge University Press, New York, USA pp. 681-688
19. Weitschies W., Karaus M., Cordini D., Trahms L., Breitkreutz J., and Semmler W. Magnetic marker monitoring of disintegrating capsules. Eur. J. Pharm. Sci. 13 (2001) 411-416
20. Andrä W., Danan H., Kirmsse W., Kramer H.H., Saupe P., Schmieg R., and Bellemann M.E. A novel method for real-time magnetic marker monitoring in the gastrointestinal tract. Phys. Med. Biol. 45 (2000) 3081-3093
21. Stathopoulos E., Schlageter V., Meyrat B., Ribaupierre Y., and Kucera P. Magnetic pill tracking: a novel non-invasive tool for investigation of human digestive motility. Neurogastroenterol. Motil. 17 (2005) 148-154
22. Andrä W., Danan H., Eitner K., Hocke M., Kramer H.H., Parusel H., Saupe P., Werner C., and Bellemann M.E. A novel magnetic method for examination of bowel motility. Med. Phys. 32 (2005) 2942-2944
23. Hocke M., Schöne U., Richert H., Görnert P., Keller J., Layer P., and Stallmach A. Every slow wave impulse is associated with motor activity of the human stomach. Am. J. Physiol. Gastrointest. Liver Physiol. 296 (2009) G709-G716
24. Dutta S., and Barzin A. Multiple magnet ingestion as a source of severe gastrointestinal complications requiring surgical intervention. Arch. Pediatr. Adolesc. Med. 162 (2008) 123-125
25. Barreiro M.A., McKenna R.D., and Beck I.T. Determination of transit in the human jejunum by the single-injection indicator-dilution technique. Am. J. Dig. Dis. 13 (1968) 222-233
26. Spiller R.C., Brown M.L., and Phillips S.F. Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility. Gastroenterology 92 (1987) 724-729
27. Weitschies W., Wedemeyer R.S., Kosch O., Fach K., Nagel S., Söderlind E., Trahms L., Abrahamsson B., and Mönnikes H. Impact of the intragastric location of extended release tablets on food interactions. J. Control. Release 108 (2005) 375-385
28. Castedal M., Bjornsson E., Gretarsdottir J., Fjalling M., and Abrahamsson H. Scintigraphic assessment of interdigestive duodenogastric reflux in humans: distinguishing between duodenal and biliary reflux material. Scand. J. Gastroenterol. 35 (2000) 590-598
29. Davis S.S., Hardy J.G., and Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 27 (1986) 886-892
30. Shafik A., El-Sibai O., and Shafik A. Physiological assessment of the function of the ileocecal junction with evidence of ileocecal junction reflexes. Med. Sci. Monit. 8 (2002) CR629-635
31. Schiller C., Fröhlich C.P., Giessmann T., Siegmund W., Mönnikes H., Hosten N., and Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22 (2005) 971-979
32. Fadda H.M., McConnell E.L., Short M.D., and Basit A.W. Meal-induced acceleration of tablet transit through the human small intestine. Pharm. Res. 26 (2009) 356-360
33. Watts P.J., Barrow L., Steed K.P., Wilson C.G., Spiller R.C., Melia C.D., and Davies M.C. The transit rate of different sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int. J. Pharm. 87 (1992) 215-221
34. Lewis S.J., and Heaton K.W. Roughage revisited (the effect on intestinal function of inert plastic particles of different sizes and shapes). Dig. Dis. Sci. 44 (1999) 744-748
35. Hertz A.F., and Newton A. The normal movements of the colon in man. Am. J. Physiol. 47 (1913) 57-65
36. Duthie H.L. Colonic response to eating. Gastroenterology 75 (1978) 527-528
37. Bergstrand M., Söderlind E., Weitschies W., and Karlsson M.O. Mechanistic modeling of a magnetic marker monitoring study, linking gastro intestinal tablet transit, in vivo drug release and pharmacokinetics. Clin. Pharmacol. Ther. (2009) 10.1038/clpt.2009.43
38. McCormack P.L., and Keating G.M. Amoxicillin/clavulanic acid 2000 mg/125 mg extended release (XR): a review of its use in the treatment of respiratory tract infections in adults. Drugs 65 (2005) 121-136
39. Garbacz G., Wedemeyer R.S., Nagel S., Giessmann T., Mönnikes H., Wilson C.G., Siegmund W., and Weitschies W. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur. J. Pharm. Biopharm. 70 (2008) 421-428
40. McConnell E.L., Fadda H.M., and Basit A.W. Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm. 364 (2008) 213-226
41. Weitschies W., Grützmann R., Hartmann V., and Breitkreutz J. Investigation of the disintegration behavior of magnetically marked tablets. Eur. J. Pharm. Biopharm. 52 (2001) 221-226
42. Weitschies W., Friedrich C., Wedemeyer R.S., Schmidtmann M., Kosch O., Kinzig M., Trahms L., Sörgel F., Siegmund W., Horkovics-Kovats S., Schwarz F., Raneburger J., and Mönnikes H. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Eur. J. Pharm. Biopharm. 70 (2008) 641-648
43. Weitschies W., Cordini D., Karaus M., Trahms L., and Semmler W. Magnetic marker monitoring of the esophageal, gastric and duodenal transit of non-disintegrating capsules. Pharmazie 54 (1999) 426-430